Home » Topics » Disease categories and therapies » Musculoskeletal

Musculoskeletal
RSS

Celltech discloses potent and selective inhibitors of protein kinases

July 15, 1997

Novel NSAID for rheumatoid arthritis characterized by Fujisawa

July 14, 1997

British Biotech describes orally active MMP/TNF inhibitors

July 14, 1997

Generic etodolac approved by FDA

July 11, 1997

Clinical evaluation of FO-726

July 10, 1997

Kanebo describes new selectin inhibitors

July 10, 1997

MMP and TNF production inhibitors described by DuPont Merck

July 9, 1997

New antiinflammatory agents from Procter & Gamble

July 8, 1997

VX-740: new lead antiinflammatory compound from Vertex/HMR

July 7, 1997

Suppressive effect of KE-298 on MMP production

July 7, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 17, 2026.
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...